Literature DB >> 16480433

Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.

Feng Zhang1, Xiaoxia Chu, Lin Wang, Yuanyuan Zhu, Lizhen Li, Daoxin Ma, Jun Peng, Ming Hou.   

Abstract

OBJECTIVES: Investigate the contribution and mechanism of cell-mediated cytotoxicity to the pathogenesis of idiopathic thrombocytopenic purpura (ITP).
METHODS: We observed the cytotoxic effect of cytotoxic T-lymphocyte (CTL) (CD8+) and natural killer cells (CD3- CD16+ CD56+) toward chronic ITP patient's autologous platelets, and investigated the expression of Fas ligand (FasL), tumor necrosis factor (TNF)-alpha and TNF-related apoptosis inducing ligand, as well as perforin and granzyme B mRNA in CD8+ cells using flow cytometry and reverse transcriptase-polymerase chain reaction.
RESULTS: We found that platelet lysis was seen only using purified CD8+ T cells as effector cells; expression of FasL and TNF-alpha in CD8+ T cells in ITP group was elevated. Moreover, the mRNA levels of granzyme B and perforin in CD8+ cells of ITP patients were increased.
CONCLUSIONS: Our findings suggest that CTLs are activated in chronic ITP and might be involved in the pathogenesis of this disorder. Apoptosis and perforin/granzyme-mediated cytotoxicity constitute an important pathway through which CTLs destruct autologous platelets. CTLs might be a reasonable target for a therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16480433     DOI: 10.1111/j.1600-0609.2005.00622.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  39 in total

Review 1.  Piecing together the humoral and cellular mechanisms of immune thrombocytopenia.

Authors:  Lisa J Toltl; Ishac Nazi; Reza Jafari; Donald M Arnold
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

Review 2.  Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.

Authors:  Lisa J Toltl; Donald M Arnold
Journal:  Br J Haematol       Date:  2010-11-18       Impact factor: 6.998

Review 3.  Advances in immunopathogenesis of adult immune thrombocytopenia.

Authors:  Xinguang Liu; Yu Hou; Jun Peng
Journal:  Front Med       Date:  2013-11-21       Impact factor: 4.592

4.  Effects of CD70 and CD11a in immune thrombocytopenia patients.

Authors:  Li Ma; Zeping Zhou; Hairong Jia; Hu Zhou; Aiping Qi; Huiyuan Li; Hongmei Wang; Lei Zhang; Renchi Yang
Journal:  J Clin Immunol       Date:  2011-05-04       Impact factor: 8.317

5.  Skewed T-cell subsets and enhanced macrophages phagocytosis in the spleen of patients with immune thrombocytopenia failing glucocorticoids.

Authors:  Xiaodong Chen; Sirui Chen; Chunlin Li; Yankun Zhu; Bing Peng
Journal:  Int J Hematol       Date:  2011-08-20       Impact factor: 2.490

6.  CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia.

Authors:  Li Ma; Elisa Simpson; June Li; Min Xuan; Miao Xu; Laura Baker; Yan Shi; Issaka Yougbaré; Xiaozhong Wang; Guangheng Zhu; Pingguo Chen; Gerald J Prud'homme; Alan H Lazarus; John Freedman; Heyu Ni
Journal:  Blood       Date:  2015-06-02       Impact factor: 22.113

Review 7.  Novel treatments for immune thrombocytopenia.

Authors:  Andrew Shih; Ishac Nazi; John G Kelton; Donald M Arnold
Journal:  Presse Med       Date:  2014-03-20       Impact factor: 1.228

8.  In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia.

Authors:  Hui Zhong; James Bussel; Karina Yazdanbakhsh
Journal:  Br J Haematol       Date:  2014-09-24       Impact factor: 6.998

9.  Eosinophil Granulocyte and NK Cell-Mediated Platelet Destruction in Immune Thrombocytopenia.

Authors:  Shuguo Wang; Fenghai Liu; Hongguo Zhao
Journal:  Indian J Hematol Blood Transfus       Date:  2017-05-17       Impact factor: 0.900

10.  Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).

Authors:  R M Talaat; A M Elmaghraby; S S Barakat; M El-Shahat
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.